"Die Innere Medizin ist eines der vielseitigsten medizinischen Fachgebiete. Entsprechend umfangreich und gleichzeitig unterschiedlich sind die Aufgaben in unserer Disziplin. In der Klinik für Innere Medizin II behandeln wir vor allem Krebserkrankungen, Blut- und Lymphdrüsenkrankheiten, aber auch gastroenterologische Erkrankungen (Magen, Darm, Leber, Galle). Bei uns sind Sie aber auch dann richtig, wenn Sie unklare Symptome haben oder Beschwerden auftreten, die Sie nicht zuordnen können. Scheuen Sie also nicht davor zurück, zu uns zu kommen, auch wenn wir nicht jedes Krankheitsbild und jede Leistung auf unserer Website aufführen können. Wir sind gerne für Sie da."

During the past decade, St. Johannes Hospital; Abt. für Hämatologie und Onkologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St. Johannes Hospital; Abt. für Hämatologie und Onkologie" are "Lymphocytic Leukemia, Chronic" (1 trials), "Lymphoma, Non Hodgkin" (1 trials), "Non-Hodgkin's Lymphoma" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "St. Johannes Hospital; Abt. für Hämatologie und Onkologie" in a lesser frequency.

Most popular intervention types in "St. Johannes Hospital; Abt. für Hämatologie und Onkologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials), "BTCT4465A (Mosunetuzumab) IV" (1 trials), "BTCT4465A (Mosunetuzumab) SC" (1 trials) and "Chemotherapy (Induction Period)" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Johannes Hospital; Abt. für Hämatologie und Onkologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "St. Johannes Hospital; Abt. für Hämatologie und Onkologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in St. Johannes Hospital; Abt. für Hämatologie und Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Johannes Hospital; Abt. für Hämatologie und Onkologie, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".